Full-Time

Senior Scientist

GPCR Pharmacology

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Biotechnology
Healthcare

Compensation Overview

$88.3k - $147.1kAnnually

+ Bonus

Senior

Cambridge, MA, USA

Relocation support available.

Category
Lab & Research
Interdisciplinary Research
Life Sciences
Requirements
  • PhD with a minimum of 2 years of post-doc or relevant research experience.
  • Deep expertise in GPCR molecular pharmacology, including hands-on experience with traditional and novel screening methodologies and concepts related to GPCR drug discovery, signaling and trafficking.
  • Scientific rigor with demonstrated ability to review critically available data and think independently and creatively in formulating and testing novel scientific hypotheses.
  • Excellent communication and interpersonal skills and ability to work independently and as part of an interdisciplinary team in a collaborative environment.
  • Successful record of scientific accomplishments supported by previous publications in high-impact pharmacology journals and presentations at international conferences.
  • Ability to mentor junior colleagues both technically and scientifically.
Responsibilities
  • Independently conceptualize, design and conduct *in vitro* studies aimed at dissecting the complex molecular pharmacology of emerging therapeutic modulators targeting GPCRs.
  • Translate experimental results to advance our understanding of receptor biology and help define how physiological endpoints are impacted by pharmacological agents.
  • Maintain an awareness of ‘cutting edge’ scientific and technical developments in preclinical to clinical translation and apply these to advance the portfolio programs.
  • Apply creative thinking and scientific expertise to the formulation of strategies to identify and validate novel therapeutic targets in key areas of interest to the IMRU.
  • Mentor junior scientists in developing skills essential to the execution of rigorous research.
  • Build and facilitate collaborations with partners in the academic scientific community, as well as within the Pfizer network of scientists.
  • Present research findings to Pfizer colleagues and the scientific community through publication in peer-reviewed journals and talks and posters at scientific meetings.
  • Present and represent research programs to Pfizer leadership.
  • Ensure that all research/discovery work is conducted with highest quality and ethical guidelines and in accordance with relevant regulatory, QC, and compliance guidelines.

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its partnership with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also initiatives to ensure that vaccines reach underserved populations. The goal of Pfizer is to enhance global health by expanding its range of effective treatments and vaccines.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?